ΑρΑ«ΚΣΖ΅

Meeting Coverage

EADV

European Academy of Dermatology and Venereology

Inflammation Marker May Spot Atopic Dermatitis Risk Early in Childhood

Elevated TARC at 2 months more than quadrupled the likelihood of moderate-severe AD at 2 years

EADV over a photo of the MiCo Milano Convention Center in Milano, Italy

Latest EADV Meeting Coverage

Gut Bacteria for Psoriasis; Long-Term Hair Growth; COVID and STDs

Selected presentations from the European Academy of Dermatology and Venereology virtual conference

November 5, 2020
Nonsteroidal Topical, Nanodrug Active in Psoriasis

Selected presentations from the European Academy of Dermatology and Venereology meeting

November 4, 2020
Atopic Dermatitis: New Topical Agent, Durable Results With Orals

Selected abstracts from the European Academy of Dermatology and Venereology Virtual Conference

November 2, 2020
First-Ever Positive Phase III Trial in Epidermolysis Bullosa

Faster wound healing with oleogel-S10, particularly in most common form of EB

November 1, 2020
Add Skin Conditions to COVID-19 Long-Hauler Effects

Persistence beyond 60 days in some cases, especially with pernio/chilblains

October 30, 2020
Early Win for Anti-IL-17 Drug in Hidradenitis Suppurativa

Responses in 14 of 18 patients with longstanding disease

September 18, 2018
JAK Agents Impress in Alopecia Areata

Significant hair growth with two different drugs

September 17, 2018
Serious Infection Risk with Biologics for Atopic Dermatitis

Double the risk associated with systemic nonbiologics

September 14, 2018
Psoriasis Response Falls as Comorbidities Rise

Comorbid conditions reported in two-thirds of patients

September 14, 2018
EADV: Psoriasis Comorbidities May Cut Longevity

BERLIN -- Psoriasis patients have a substantial comorbidity burden that can reduce life expectancy by 10 years or more, according to data presented here.

October 14, 2009

Latest Dermatology Meeting Coverage